Galera Therapeutics Inc. (GRTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Galera Therapeutics Inc.

    OTC: GRTX · Real-Time Price · USD
    0.03
    0.00 (9.09%)
    At close: Apr 04, 2025, 2:24 PM

    Galera Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 8.29M 18.26M 4.27M 19.86M
    Short-Term Investments
    		 n/a n/a 27.33M 51.36M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 100K 90K 1.88M 1.96M
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 1.71M 3.37M 6.94M 6.17M
    Total Current Assets
    		 10M 21.63M 38.53M 77.39M
    Property-Plant & Equipment
    		 n/a 1.28M 481K 823K
    Goodwill & Intangibles
    		 n/a 3.14M 3.14M 3.14M
    Total Long-Term Assets
    		 100K 4.51M 5.5M 5.92M
    Total Assets
    		 10.1M 26.14M 44.04M 83.31M
    Account Payables
    		 1.27M 1.38M 3.58M 5.04M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 44K 258K
    Other Current Liabilities
    		 391K 121K 2.61M 1.78M
    Total Current Liabilities
    		 1.67M 4.96M 13.38M 12.94M
    Long-Term Debt
    		 n/a 1.12M 139.63M n/a
    Other Long-Term Liabilities
    		 152.1M 149.93M n/a 128.06M
    Total Long-Term Liabilities
    		 152.1M 152.37M 139.84M 128.38M
    Total Liabilities
    		 153.77M 157.33M 153.22M 141.31M
    Total Debt
    		 n/a 1.25M 44K 302K
    Common Stock
    		 75K 54K 28K 26K
    Retained Earnings
    		 -456.36M -437.41M -378.32M -316.1M
    Comprehensive Income
    		 n/a n/a -22K -14K
    Shareholders Equity
    		 -143.67M -131.19M -109.18M -58M
    Total Investments
    		 n/a n/a 27.33M 51.36M

    Add to Watchlist